NASDAQ:TNON
Tenon Medical, Inc.
Tenon Medical, Inc.'s revenue grew 20.4% in fiscal 2025 to $3.9M while operating margin rose to −324.3%, its highest in 5 years. Free cash flow was −$11.0M, −279.4% of revenue, and the diluted share count rose 508.2%.Summary generated from Tenon Medical, Inc.'s SEC filings. Latest annual report filed Mar 27, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$3.9M
Revenue growth+20.4%
Revenue, 5-yr CAGRn/a
Gross margin59.8%
Operating margin−324.3%
Net margin−318.4%
ROICn/a
Return on equity−228.1%
Debt / equityn/a
Free cash flow−$11.0M
FCF margin−279.4%
Share count change+508.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 3 | 3 | 4 |
| Operating income | −6 | −19 | −16 | −14 | −13 |
| Net income | −7 | −19 | −16 | −14 | −13 |
| Free cash flow | −4 | −13 | −13 | −10 | −11 |
Recent filings
- 8-KEntry into a material agreement
Sep 16, 2026 - 4Insider transaction report
Sep 11, 2026 - 4Insider transaction report
Sep 10, 2026 - 8-KOther events
Sep 9, 2026 - 8-KEntry into a material agreement
Aug 31, 2026 - 8-K/AAmended entry into a material agreement
Aug 26, 2026 - 8-KOther events
Aug 24, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026